Close Menu

NEW YORK (GenomeWeb News) – SynapDx today announced a collaboration with the Broad Institute to develop next-generation sequencing analysis methods to improve autism diagnostics.

Specifically, the techniques will be aimed at improving test accuracy and clinical utility, Lexington, Mass.-based SynapDx said. The company is currently conducting large, prospective, multicenter studies to analyze blood from children who are being clinically evaluated for autism spectrum disorder.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.